MERIDIAN INVESTMENT COUNSEL INC. - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 143 filers reported holding IMMUNITYBIO INC in Q4 2021. The put-call ratio across all filers is 4.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
MERIDIAN INVESTMENT COUNSEL INC. ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$162,972
-39.2%
96,4330.0%0.06%
-36.5%
Q2 2023$268,084
+52.7%
96,4330.0%0.10%
+43.3%
Q1 2023$175,508
+35791.2%
96,4330.0%0.07%
-65.6%
Q4 2022$489
-99.9%
96,4330.0%0.20%
-8.5%
Q3 2022$479,000
+33.4%
96,4330.0%0.21%
+43.9%
Q2 2022$359,000
-33.6%
96,4330.0%0.15%
-21.3%
Q1 2022$541,000
-7.7%
96,4330.0%0.19%
-3.6%
Q4 2021$586,000
-37.6%
96,4330.0%0.20%
-42.8%
Q3 2021$939,000
-31.8%
96,4330.0%0.34%
-29.7%
Q2 2021$1,377,000
-39.8%
96,4330.0%0.48%
-45.1%
Q1 2021$2,289,00096,4330.88%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$4,180,0000.56%
HARBOURVEST PARTNERS LLC 335,709$2,041,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$586,0000.20%
SHEETS SMITH WEALTH MANAGEMENT 152,276$926,0000.12%
GSA CAPITAL PARTNERS LLP 129,260$786,0000.10%
Clearwater Capital Advisors, LLC 140,551$855,0000.09%
Virtus ETF Advisers LLC 28,969$176,0000.07%
XTX Topco Ltd 19,159$116,0000.07%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 49,464$301,0000.04%
Vident Investment Advisory, LLC 168,476$1,024,0000.03%
View complete list of IMMUNITYBIO INC shareholders